Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now lists 99 locations for the study, an increase from the previous 98 locations, and includes specific contact information for the Manitoba site, including the principal investigator's name, Ashley Chopek.
    Difference
    0.5%
    Check dated 2025-03-14T07:05:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has removed key contact information and details about a principal investigator, while also adding new dates related to the content. Additionally, the status has changed to 'Suspended'.
    Difference
    0.4%
    Check dated 2025-03-07T01:10:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has updated key personnel information, replacing Kathleen J. Yost with Kathleen Y. Butler and adding Iftikhar Hanif as the Principal Investigator. Additionally, the contact information has been updated.
    Difference
    0.4%
    Check dated 2025-02-27T20:08:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-02-20T17:17:41.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with updated dates for February 2025. Previous dates from late January 2025 have been removed.
    Difference
    0.7%
    Check dated 2025-02-12T10:13:19.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.14.2 and has suspended certain features, while previous content related to recruiting and contact information has been removed.
    Difference
    0.3%
    Check dated 2025-02-05T06:17:33.000Z thumbnail image

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.